Filing Details

Accession Number:
0001396677-13-000043
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-06-19 18:09:43
Reporting Period:
2013-06-17
Filing Date:
2013-06-19
Accepted Time:
2013-06-19 18:09:43
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1050007 Nutraceutical International Corp NUTR Medicinal Chemicals & Botanical Products (2833) 870515089
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1276716 Kimo J Esplin C/O Nutraceutical International Corp
1400 Kearns Blvd
Park City UT 84060
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-06-17 1,814 $11.53 7,114 No 4 M Direct
Common Stock Disposition 2013-06-17 1,814 $20.09 5,300 No 4 S Direct
Common Stock Acquisiton 2013-06-18 5,686 $11.53 10,986 No 4 M Direct
Common Stock Disposition 2013-06-18 5,686 $20.01 5,300 No 4 S Direct
Common Stock Acquisiton 2013-06-18 2,500 $11.53 7,800 No 4 M Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Director Stock Option Disposition 2013-06-17 1,814 $0.00 1,814 $11.53
Common Stock Director Stock Option Disposition 2013-06-18 8,186 $0.00 8,186 $11.53
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
8,186 2014-01-09 No 4 M Direct
0 2014-01-09 No 4 M Direct
Footnotes
  1. Exercise of options expiring on January 9, 2014.
  2. The price shown in Column 4 is a weighted average sale price. The price range for the sales is $20.0000 to $20.27. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  3. The price shown in Column 4 is a weighted average sale price. The price range for the sales is $20.0000 to $20.0134. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  4. The option vested in twelve equal installments every three months beginning on March 31, 2004.